Public Law 119–44: To reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.Public Law44Public Law 119–44139 Stat. 6692025-12-012025-12-01United States Government Publishing OfficeNational Archives and Records AdministrationOffice of the Federal Registertext/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.GPO Locator to USLM Converter 4.15.31;Stage2.202507022025-12-09119publicPUBLIC LAW 119–44—DEC. 1, 2025139 STAT. 669Public Law119–44119th CongressAn ActTo reauthorize certain programs that provide for opioid use disorder prevention, treatment, and recovery, and for other purposes.
Dec. 1, 2025
[H.R. 2483]
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SUPPORT for Patients and Communities Reauthorization Act of 2025.
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.(a)
42 USC 201 note.
Short Title.—This Act may be cited as the “SUPPORT for Patients and Communities Reauthorization Act of 2025”.(b) Table of Contents.—The table of contents for this Act is as follows:Sec. 1. TITLE I—Sec. 101. Sec. 102. Sec. 103. Sec. 104. Sec. 105. Sec. 106. Sec. 107. Sec. 108. Sec. 109. Sec. 110. Sec. 111. Sec. 112. Sec. 113. TITLE II—Sec. 201. Sec. 202. Sec. 203. Sec. 204. Sec. 205. Sec. 206. Sec. 207. Sec. 208. Sec. 209. Sec. 210. Sec. 211. TITLE III—Sec. 301. Sec. 302. Sec. 303. Sec. 304. Sec. 305. Sec. 306. Sec. 307. TITLE IV—Sec. 401. Sec. 402. <num value="I">TITLE I—</num><heading>PREVENTION</heading>
<section id="d3755e321" identifier="/us/pl/119/44/tI/s101" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="101">SEC. 101. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f56ee54-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><heading>PRENATAL AND POSTNATAL HEALTH.</heading><content style="-uslm-lc:I658120"> Section 317L(d) of the Public Health Service Act (<ref href="/us/usc/t42/s247b–13/d">42 U.S.C. 247b–13(d)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> “<quotedText>such sums as may be necessary for each of the fiscal years 2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$4,250,000 for each of fiscal years 2026 through 2030</quotedText>”.</content></section>
<section id="d3755e343" identifier="/us/pl/119/44/tI/s102" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="102">SEC. 102. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f56ee55-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><heading>MONITORING AND EDUCATION REGARDING INFECTIONS ASSOCIATED WITH ILLICIT DRUG USE AND OTHER RISK FACTORS.</heading><content style="-uslm-lc:I658120"> Section 317N(d) of the Public Health Service Act (<ref href="/us/usc/t42/s247b–15/d">42 U.S.C. 247b–15(d)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> “<quotedText>fiscal years 2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>fiscal years 2026 through 2030</quotedText>”.</content></section>
<section id="d3755e365" identifier="/us/pl/119/44/tI/s103" style="-uslm-lc:I658143"><num class="fontsize12" value="103">SEC. 103. </num><heading>PREVENTING OVERDOSES OF CONTROLLED SUBSTANCES.</heading><subsection class="firstIndent0 fontsize10" id="y7f57d8b6-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">In General</inline>.—</heading><chapeau>Section 392A of the Public Health Service Act (<ref href="/us/usc/t42/s280b–1">42 U.S.C. 280b–1</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f57d8b7-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><chapeau>in subsection (a)(2)—</chapeau><subparagraph class="fontsize10" id="y7f57d8b8-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a/1/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in subparagraph (C), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>and associated risks</quotedText>” before the period at the end; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f57d8b9-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a/1/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in subparagraph (D), by <amendingAction type="delete">striking</amendingAction> “<quotedText>opioids</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>substances causing overdose</quotedText>”; and</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f57d8ba-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in subsection (b)(2)—</chapeau><subparagraph class="fontsize10" id="y7f57d8bb-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in subparagraph (B), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>, and associated risk factors,</quotedText>” after “<quotedText>such overdoses</quotedText>”;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f57d8bc-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in subparagraph (C), by <amendingAction type="delete">striking</amendingAction> “<quotedText>coding</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>monitoring and identifying</quotedText>”;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f57d8bd-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a/2/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><chapeau>in subparagraph (E)—</chapeau><clause class="fontsize10" id="y7f57d8be-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a/2/C/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content>by <amendingAction type="insert">inserting</amendingAction> a comma after “<quotedText>public health laboratories</quotedText>”; and</content></clause>
<clause class="fontsize10" id="y7f57d8bf-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a/2/C/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>and other emerging substances related</quotedText>” after “<quotedText>analogues</quotedText>”; and</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="y7f57d8c0-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/a/2/D" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">(D) </num><content>in subparagraph (F), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>and associated risk factors</quotedText>” after “<quotedText>overdoses</quotedText>”.</content></subparagraph>
</paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f57d8c1-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/b" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Additional Grants</inline>.—</heading><chapeau>Section 392A(a)(3) of the Public Health Service Act (<ref href="/us/usc/t42/s280b–1/a/3">42 U.S.C. 280b–1(a)(3)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f57d8c2-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in the matter preceding subparagraph (A), by <amendingAction type="delete">striking</amendingAction> “<quotedText>and Indian Tribes—</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>and Indian Tribes for the following purposes:</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="y7f57d8c3-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="amend">amending</amendingAction> subparagraph (A) to read as follows:<quotedContent><subparagraph class="fontsize10" id="y7f57ffd4-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>To carry out innovative projects for grantees to detect, identify, and rapidly respond to controlled substance misuse, abuse, and overdoses, and associated risk factors, including changes in patterns of such controlled substance use. Such projects may include the use of innovative, evidence-based strategies for detecting such patterns, such as wastewater surveillance, if proven to support actionable <page identifier="/us/stat/139/671">139 STAT. 671</page>
prevention strategies, in a manner consistent with applicable Federal and State privacy laws.”</content></subparagraph>
</quotedContent>; and</content></paragraph>
<paragraph class="fontsize10" id="y7f57ffd5-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/b/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>in subparagraph (B), by <amendingAction type="delete">striking</amendingAction> “<quotedText>for any</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>For any</quotedText>”.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f57ffd6-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s103/c" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">(c) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f57ffd7-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><heading class="fontsize10"><inline class="smallCaps">Authorization of Appropriations</inline>.—</heading><content>Section 392A(e) of the Public Health Service Act (<ref href="/us/usc/t42/s280b–1/e">42 U.S.C. 280b–1(e)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> “<quotedText>$496,000,000 for each of fiscal years 2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$505,579,000 for each of fiscal years 2026 through 2030</quotedText>”.</content></subsection>
</section>
<section id="d3755e555" identifier="/us/pl/119/44/tI/s104" style="-uslm-lc:I658143"><num class="fontsize12" value="104">SEC. 104. </num><heading>SUPPORT FOR INDIVIDUALS AND FAMILIES IMPACTED BY FETAL ALCOHOL SPECTRUM DISORDER.</heading><subsection class="firstIndent0 fontsize10" id="y7f58ea38-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s104/a" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">In General</inline>.—</heading><content>Part O of title III of the Public Health Service Act (<ref href="/us/usc/t42/s280f/etseq">42 U.S.C. 280f et seq.</ref>) <amendingAction type="amend">is amended</amendingAction> to read as follows:<quotedContent><part id="y7f59fba9-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658173"><num class="fontsize12 bold" value="O">“PART O—</num><heading class="fontsize12 bold">FETAL ALCOHOL SPECTRUM DISORDER PREVENTION AND SERVICES PROGRAM</heading><section class="indentUp2 firstIndent-2" id="y7f59fbaa-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658144"><num class="bold" value="399H">“SEC. 399H. </num><heading class="bold">FETAL ALCOHOL SPECTRUM DISORDERS PREVENTION, INTERVENTION, AND SERVICES DELIVERY PROGRAM.</heading><subsection class="indentDown2 firstIndent0 fontsize10" id="y7f59fbab-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">“(a) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f59fbac-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Evaluations.</p></sidenote><inline class="smallCaps">In General</inline>.—</heading><chapeau>The Secretary shall establish or continue activities to support a comprehensive fetal alcohol spectrum disorders (referred to in this section as ‘FASD’) education, prevention, identification, intervention, and services delivery program, which may include—</chapeau><paragraph class="fontsize10" id="y7f59fbad-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><chapeau>an education and public awareness program to support, conduct, and evaluate the effectiveness of—</chapeau><subparagraph class="fontsize10" id="y7f59fbae-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>educational programs targeting health professions schools, social and other supportive services, educators and counselors and other service providers in all phases of childhood development, and other relevant service providers, concerning the prevention, identification, and provision of services for infants, children, adolescents, and adults with FASD;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f59fbaf-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><content>strategies to educate school-age children, including pregnant and high-risk youth, concerning FASD;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f59fbb0-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">“(C) </num><content>public and community awareness programs concerning FASD; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f59fbb1-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">“(D) </num><content>strategies to coordinate information and services across affected community agencies, including agencies providing social services such as foster care, adoption, and social work, agencies providing health services, and agencies involved in education, vocational training, and civil and criminal justice;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f59fbb2-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><chapeau>supporting and conducting research on FASD, as appropriate, including to—</chapeau><subparagraph class="fontsize10" id="y7f59fbb3-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>develop appropriate medical diagnostic methods for identifying FASD; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f59fbb4-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><content>develop effective culturally and linguistically appropriate evidence-based or evidence-informed interventions and appropriate supports for preventing prenatal alcohol exposure, which may co-occur with exposure to other substances;<page identifier="/us/stat/139/672">139 STAT. 672</page></content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f5a22c5-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">“(3) </num><chapeau>building State and Tribal capacity for the identification, treatment, and support of individuals with FASD and their families, which may include—</chapeau><subparagraph class="fontsize10" id="y7f5a22c6-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>utilizing and adapting existing Federal, State, or Tribal programs to include FASD identification and FASD-informed support;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5a22c7-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><content>developing and expanding screening and diagnostic capacity for FASD;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5a22c8-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">“(C) </num><content>developing, implementing, and evaluating targeted FASD-informed intervention programs for FASD;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5a22c9-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">“(D) </num><content>providing training with respect to FASD for professionals across relevant sectors; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5a22ca-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="E">“(E) </num><content>disseminating information about FASD and support services to affected individuals and their families; and</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f5a22cb-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">“(4) </num><content>an applied research program concerning intervention and prevention to support and conduct service demonstration projects, clinical studies and other research models providing advocacy, educational and vocational training, counseling, medical and mental health, and other supportive services, as well as models that integrate and coordinate such services, that are aimed at the unique challenges facing individuals with fetal alcohol spectrum disorder or fetal alcohol effect and their families.</content></paragraph>
</subsection>
<subsection class="indentDown2 firstIndent0 fontsize10" id="y7f5a22cc-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">“(b) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5a22cd-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Contracts.</p></sidenote><heading class="fontsize10"><inline class="smallCaps">Grants and Technical Assistance</inline>.—</heading><paragraph class="fontsize10" id="y7f5a22ce-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><heading class="fontsize10"><inline class="smallCaps">In general</inline>.—</heading><content>The Secretary may award grants, cooperative agreements and contracts and provide technical assistance to eligible entities to carry out subsection (a).</content></paragraph>
<paragraph class="fontsize10" id="y7f5a22cf-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><heading class="fontsize10"><inline class="smallCaps">Eligible entities</inline>.—</heading><chapeau>To be eligible to receive a grant, or enter into a cooperative agreement or contract, under this section, an entity shall—</chapeau><subparagraph class="fontsize10" id="y7f5a22d0-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>be a State, Indian Tribe or Tribal organization, local government, scientific or academic institution, or nonprofit organization; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5a22d1-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><content>prepare and submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require, including a description of the activities that the entity intends to carry out using amounts received under this section.</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f5a22d2-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">“(3) </num><heading class="fontsize10"><inline class="smallCaps">Additional application contents</inline>.—</heading><chapeau>The Secretary may require that an eligible entity include in the application submitted under paragraph (2)(B)—</chapeau><subparagraph class="fontsize10" id="y7f5a22d3-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>a designation of an individual to serve as a FASD State or Tribal coordinator of activities such eligible entity proposes to carry out through a grant, cooperative agreement, or contract under this section; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5a22d4-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><content>a description of an advisory committee the entity will establish to provide guidance for the entity on developing and implementing a statewide or Tribal strategic plan to prevent FASD and provide for the identification, treatment, and support of individuals with FASD and their families.</content></subparagraph>
</paragraph>
</subsection>
<subsection class="indentDown2 firstIndent0 fontsize10" id="y7f5a22d5-d532-11f0-b8a8-e1b4a9a7cc9b" role="definitions" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">“(c) </num><heading class="fontsize10"><inline class="smallCaps">Definition of FASD-Informed</inline>.—</heading><content>For purposes of this section, the term ‘<term>FASD-informed</term>’, with respect to support or an intervention program, means that such support or intervention program uses culturally and linguistically informed evidence-based or practice-based interventions and appropriate resources to support an <page identifier="/us/stat/139/673">139 STAT. 673</page>
improved quality of life for an individual with FASD and the family of such individual.</content></subsection>
</section>
<section class="indentUp2 firstIndent-2" id="y7f5a22d6-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658144"><num class="bold" value="399I">“SEC. 399I. </num><heading class="bold"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5a22d7-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180"><ref href="/us/usc/t42/s280f–1">42 USC 280f–1</ref>.</p></sidenote>STRENGTHENING CAPACITY AND EDUCATION FOR FETAL ALCOHOL SPECTRUM DISORDERS.</heading><subsection class="indentDown2 firstIndent0 fontsize10" id="y7f5a22d8-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">“(a) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5a22d9-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Grants.</p></sidenote><inline class="smallCaps">In General</inline>.—</heading><content>The Secretary shall award grants, contracts, or cooperative agreements, as the Secretary determines appropriate, to public or nonprofit private entities with demonstrated expertise in the field of fetal alcohol spectrum disorders (referred to in this section as ‘FASD’). Such awards shall be for the purposes of building local, Tribal, State, and nationwide capacities to prevent the occurrence of FASD by carrying out the programs described in subsection (b).</content></subsection>
<subsection class="indentDown2 firstIndent0 fontsize10" id="y7f5a22da-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">“(b) </num><heading class="fontsize10"><inline class="smallCaps">Programs</inline>.—</heading><chapeau>An entity receiving an award under subsection (a) may use such award for the following purposes:</chapeau><paragraph class="fontsize10" id="y7f5a22db-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><content>Developing and supporting public education and outreach activities to raise public awareness of the risks associated with alcohol consumption during pregnancy.</content></paragraph>
<paragraph class="fontsize10" id="y7f5a22dc-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><content><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5a22dd-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Clearinghouse.</p></sidenote>Acting as a clearinghouse for evidence-based resources on FASD prevention, identification, and culturally and linguistically appropriate best practices to help inform systems of care for individuals with FASD across their lifespan.</content></paragraph>
<paragraph class="fontsize10" id="y7f5a22de-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">“(3) </num><content>Increasing awareness and understanding of efficacious, evidence-based screening tools and culturally and linguistically appropriate evidence-based intervention services and best practices, which may include improving the capacity for State, Tribal, and local affiliates.</content></paragraph>
<paragraph class="fontsize10" id="y7f5a22df-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">“(4) </num><content>Providing technical assistance to recipients of grants, cooperative agreements, or contracts under section 399H, as appropriate.</content></paragraph>
</subsection>
<subsection class="indentDown2 firstIndent0 fontsize10" id="y7f5a49f0-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">“(c) </num><heading class="fontsize10"><inline class="smallCaps">Application</inline>.—</heading><content>To be eligible for a grant, contract, or cooperative agreement under this section, an entity shall submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require.</content></subsection>
<subsection class="indentDown2 firstIndent0 fontsize10" id="y7f5a49f1-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="d">“(d) </num><heading class="fontsize10"><inline class="smallCaps">Subcontracting</inline>.—</heading><chapeau>A public or private nonprofit entity may carry out the following activities required under this section through contracts or cooperative agreements with other public and private nonprofit entities with demonstrated expertise in FASD:</chapeau><paragraph class="fontsize10" id="y7f5a49f2-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><content>Resource development and dissemination.</content></paragraph>
<paragraph class="fontsize10" id="y7f5a49f3-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><content>Intervention services.</content></paragraph>
<paragraph class="fontsize10" id="y7f5a49f4-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">“(3) </num><content>Training and technical assistance.</content></paragraph>
</subsection>
</section>
<section class="indentUp2 firstIndent-2" id="y7f5a49f5-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658144"><num class="bold" value="399J">“SEC. 399J. </num><heading class="bold"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5a49f6-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180"><ref href="/us/usc/t42/s280f–2">42 USC 280f–2</ref>.</p></sidenote>AUTHORIZATION OF APPROPRIATIONS.</heading><content class="indentDown2 firstIndent0 fontsize10" style="-uslm-lc:I658120"> “There<sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5a49f7-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote> are authorized to be appropriated to carry out this part $12,500,000 for each of fiscal years 2026 through 2030.”</content></section>
</part>
</quotedContent>.</content></subsection>
<subsection class="firstIndent0 fontsize10" id="y7f5a49f8-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s104/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5a49f9-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180"><ref href="/us/usc/t42/s280f">42 USC 280f note</ref>.</p></sidenote><heading class="fontsize10"><inline class="smallCaps">Report</inline>.—</heading><chapeau>Not later than 4 years after the date of enactment of this Act, and every year thereafter, the Secretary of Health and Human Services shall prepare and submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report containing—</chapeau><paragraph class="fontsize10" id="y7f5a49fa-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s104/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>a review of the activities carried out pursuant to sections 399H and 399I of the Public Health Service Act, as amended, to advance public education and awareness of fetal alcohol spectrum disorders (referred to in this section as “FASD”);</content></paragraph>
<paragraph class="fontsize10" id="y7f5a49fb-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s104/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>a description of—</chapeau><subparagraph class="fontsize10" id="y7f5a49fc-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s104/b/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>the activities carried out pursuant to such sections 399H and 399I to identify, prevent, and treat FASD; and<page identifier="/us/stat/139/674">139 STAT. 674</page></content></subparagraph>
<subparagraph class="fontsize10" id="y7f5a49fd-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s104/b/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>methods used to evaluate the outcomes of such activities; and</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f5a49fe-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s104/b/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>an assessment of activities carried out pursuant to such sections 399H and 399I to support individuals with FASD.</content></paragraph>
</subsection>
</section>
<section id="d3755e900" identifier="/us/pl/119/44/tI/s105" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="105">SEC. 105. </num><heading>PROMOTING STATE CHOICE IN PDMP SYSTEMS.</heading><content class="firstIndent0 fontsize10" id="x7f5a710f-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"> Section 399O(h) of the Public Health Service Act (<ref href="/us/usc/t42/s280g–3/h">42 U.S.C. 280g–3(h)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="add">adding</amendingAction> at the end the following:<quotedContent><paragraph class="fontsize10" id="y7f5a7110-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="5">“(5) </num><heading class="fontsize10"><inline class="smallCaps">Promoting state choice</inline>.—</heading><content>Nothing in this section shall be construed to authorize the Secretary to require States to use a specific vendor or a specific interoperability connection other than to align with nationally recognized, consensus-based open standards, such as in accordance with sections 3001 and 3004.”</content></paragraph>
</quotedContent>.</content></section>
<section id="d3755e928" identifier="/us/pl/119/44/tI/s106" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="106">SEC. 106. </num><heading>FIRST RESPONDER TRAINING PROGRAM.</heading><chapeau class="indentUp0 firstIndent0 fontsize10" id="x7f5b0d51-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"> Section 546 of the Public Health Service Act (<ref href="/us/usc/t42/s290ee–1">42 U.S.C. 290ee–1</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f5b0d52-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in subsection (a), by <amendingAction type="delete">striking</amendingAction> “<quotedText>tribes and tribal</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>Tribes and Tribal</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="y7f5b0d53-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in subsections (a), (c), and (d)—</chapeau><subparagraph class="fontsize10" id="y7f5b0d54-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>approved or cleared</quotedText>” each place it appears and <amendingAction type="insert">inserting</amendingAction> “<quotedText>approved, cleared, or otherwise legally marketed</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5b0d55-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>opioid</quotedText>” each place it appears;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f5b0d56-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><chapeau>in subsection (f)—</chapeau><subparagraph class="fontsize10" id="y7f5b0d57-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/3/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>approved or cleared</quotedText>” each place it appears and <amendingAction type="insert">inserting</amendingAction> “<quotedText>approved, cleared, or otherwise legally marketed</quotedText>”;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5b0d58-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/3/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in paragraph (1), by <amendingAction type="delete">striking</amendingAction> “<quotedText>opioid</quotedText>”;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5b0d59-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/3/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><chapeau>in paragraph (2)—</chapeau><clause class="fontsize10" id="y7f5b0d5a-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/3/C/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>opioid and heroin</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>opioid, heroin, and other drug</quotedText>”; and</content></clause>
<clause class="fontsize10" id="y7f5b0d5b-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/3/C/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>opioid overdose</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>overdose</quotedText>”; and</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="y7f5b0d5c-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/3/D" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">(D) </num><content>in paragraph (3), by <amendingAction type="delete">striking</amendingAction> “<quotedText>opioid and heroin</quotedText>”; and</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f5b0d5d-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s106/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><content><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5b0d5e-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote>in subsection (h), by <amendingAction type="delete">striking</amendingAction> “<quotedText>$36,000,000 for each of fiscal years 2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$57,000,000 for each of fiscal years 2026 through 2030</quotedText>”.</content></paragraph>
</section>
<section id="d3755e1058" identifier="/us/pl/119/44/tI/s107" style="-uslm-lc:I658143"><num class="fontsize12" value="107">SEC. 107. </num><heading>DONALD J. COHEN NATIONAL CHILD TRAUMATIC STRESS INITIATIVE.</heading><subsection class="firstIndent0 fontsize10" id="y7f5bf7bf-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/a" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">Technical Amendment</inline>.—</heading><chapeau>The second part G of title V of the Public Health Service Act (<ref href="/us/usc/t42/s290kk/etseq">42 U.S.C. 290kk et seq.</ref>), as added by section 144 of the Community Renewal Tax Relief Act of 2000 (<ref href="/us/pl/106/554">Public Law 106–554</ref>), <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f5bf7c0-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> such part as part J; and</content></paragraph>
<paragraph class="fontsize10" id="y7f5bf7c1-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5bf7c2-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">42 USC</p><p class="leftAlign firstIndent0 fontsize8" id="x7f5bf7c3-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">290kk—</p><p class="leftAlign firstIndent0 fontsize8" id="x7f5bf7c4-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">290kk–3.</p></sidenote><content>by <amendingAction type="redesignate">redesignating</amendingAction> sections 581 through 584 as sections 596 through 596C, respectively.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f5bf7c5-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">In General</inline>.—</heading><chapeau>Section 582 of the Public Health Service Act (<ref href="/us/usc/t42/s290hh–1">42 U.S.C. 290hh–1</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f5bf7c6-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in the section heading, by <amendingAction type="delete">striking</amendingAction> “<quotedText>violence related stress</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>traumatic events</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="y7f5bf7c7-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in subsection (a)—</chapeau><subparagraph class="fontsize10" id="y7f5bf7c8-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in the matter preceding paragraph (1), by <amendingAction type="delete">striking</amendingAction> “<quotedText>tribes and tribal</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>Tribes and Tribal</quotedText>”; and<page identifier="/us/stat/139/675">139 STAT. 675</page></content></subparagraph>
<subparagraph class="fontsize10" id="y7f5c1ed9-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in paragraph (2), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>and dissemination</quotedText>” after “<quotedText>the development</quotedText>”;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f5c1eda-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>in subsection (b), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>and dissemination</quotedText>” after “<quotedText>the development</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="y7f5c1edb-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><chapeau>in subsection (d)—</chapeau><subparagraph class="fontsize10" id="y7f5c1edc-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/4/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>The NCTSI</quotedText>” and <amendingAction type="insert">inserting</amendingAction> the following:<quotedContent><paragraph class="indentDown1 fontsize10" id="y7f5c1edd-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><heading class="fontsize10"><inline class="smallCaps">Coordinating center</inline>.—</heading><content>The NCTSI”</content></paragraph>
</quotedContent>; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5c1ede-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/4/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="add">adding</amendingAction> at the end the following:<quotedContent><paragraph class="indentDown1 fontsize10" id="y7f5c1edf-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><heading class="fontsize10"><inline class="smallCaps">NCTSI grantees</inline>.—</heading><content>In carrying out subsection (a)(2), NCTSI grantees shall develop trainings and other resources, as applicable and appropriate, to support implementation of the evidence-based practices developed and disseminated under such subsection.”</content></paragraph>
</quotedContent>;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f5c1ee0-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/5" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="5">(5) </num><chapeau>in subsection (e)—</chapeau><subparagraph class="fontsize10" id="y7f5c1ee1-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/5/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> paragraphs (1) and (2) as subparagraphs (A) and (B), respectively, and adjusting the margins accordingly;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5c1ee2-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/5/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in subparagraph (A), as so redesignated, by <amendingAction type="insert">inserting</amendingAction> “<quotedText>and implementation</quotedText>” after “<quotedText>the dissemination</quotedText>”;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5c1ee3-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/5/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>The NCTSI</quotedText>” and <amendingAction type="insert">inserting</amendingAction> the following:<quotedContent><paragraph class="indentDown1 fontsize10" id="y7f5c1ee4-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><heading class="fontsize10"><inline class="smallCaps">Coordinating center</inline>.—</heading><content>The NCTSI”</content></paragraph>
</quotedContent>; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f5c45f5-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/5/D" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">(D) </num><content>by <amendingAction type="add">adding</amendingAction> at the end the following:<quotedContent><paragraph class="indentDown1 fontsize10" id="y7f5c45f6-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><heading class="fontsize10"><inline class="smallCaps">NCTSI grantees</inline>.—</heading><content>NCTSI grantees shall, as appropriate, collaborate with other such grantees, the NCTSI coordinating center, and the Secretary in carrying out subsections (a)(2) and (d)(2).”</content></paragraph>
</quotedContent>;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f5c45f7-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/6" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="6">(6) </num><content>by <amendingAction type="amend">amending</amendingAction> subsection (h) to read as follows:<quotedContent><subsection class="indentDown1 firstIndent0 fontsize10" id="y7f5c45f8-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="h">“(h) </num><heading class="fontsize10"><inline class="smallCaps">Application and Evaluation</inline>.—</heading><chapeau>To be eligible to receive a grant, contract, or cooperative agreement under subsection (a), a public or nonprofit private entity or an Indian Tribe or Tribal organization shall submit to the Secretary an application at such time, in such manner, and containing such information and assurances as the Secretary may require, including—</chapeau><paragraph class="fontsize10" id="y7f5c6d09-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><content><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5c6d0a-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Plan.</p></sidenote>a plan for the evaluation of the activities funded under the grant, contract, or agreement, including both process and outcomes evaluation, and the submission of an evaluation at the end of the project period; and</content></paragraph>
<paragraph class="fontsize10" id="y7f5c6d0b-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><content>a description of how such entity, Indian Tribe, or Tribal organization will support efforts led by the Secretary or the NCTSI coordinating center, as applicable, to evaluate activities carried out under this section.”</content></paragraph>
</subsection>
</quotedContent>; and</content></paragraph>
<paragraph class="fontsize10" id="y7f5c6d0c-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s107/b/7" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="7">(7) </num><content>by <amendingAction type="amend">amending</amendingAction> subsection (j) to read as follows:<quotedContent><subsection class="indentDown1 firstIndent0 fontsize10" id="y7f5c941d-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="j">“(j) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5c941e-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><inline class="smallCaps">Authorization of Appropriations</inline>.—</heading><chapeau>There is authorized to be appropriated to carry out this section—</chapeau><paragraph class="fontsize10" id="y7f5c941f-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><content>$98,887,000 for fiscal year 2026;</content></paragraph>
<paragraph class="fontsize10" id="y7f5c9420-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><content>$98,887,000 for fiscal year 2027;</content></paragraph>
<paragraph class="fontsize10" id="y7f5c9421-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">“(3) </num><content>$98,887,000 for fiscal year 2028;</content></paragraph>
<paragraph class="fontsize10" id="y7f5c9422-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">“(4) </num><content>$100,000,000 for fiscal year 2029; and</content></paragraph>
<paragraph class="fontsize10" id="y7f5c9423-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="5">“(5) </num><content>$100,000,000 for fiscal year 2030.”</content></paragraph>
</subsection>
</quotedContent>.</content></paragraph>
</subsection>
</section>
<section id="d3755e1370" identifier="/us/pl/119/44/tI/s108" style="-uslm-lc:I658143"><num class="fontsize12" value="108">SEC. 108. </num><heading>PROTECTING SUICIDE PREVENTION LIFELINE FROM CYBERSECURITY INCIDENTS.</heading><subsection class="firstIndent0 fontsize10" id="y7f5d3064-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s108/a" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">National Suicide Prevention Lifeline Program</inline>.—</heading><chapeau>Section 520E–3(b) of the Public Health Service Act (<ref href="/us/usc/t42/s290bb–36c/b">42 U.S.C. 290bb–36c(b)</ref>) <amendingAction type="amend">is amended</amendingAction>—<page identifier="/us/stat/139/676">139 STAT. 676</page></chapeau><paragraph class="fontsize10" id="y7f5d3065-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s108/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in paragraph (4), by <amendingAction type="delete">striking</amendingAction> “<quotedText>and</quotedText>” at the end;</content></paragraph>
<paragraph class="fontsize10" id="y7f5d3066-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s108/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>in paragraph (5), by <amendingAction type="delete">striking</amendingAction> the period at the end and <amendingAction type="insert">inserting</amendingAction> “<quotedText>; and</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="y7f5d3067-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s108/a/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>by <amendingAction type="add">adding</amendingAction> at the end the following:<quotedContent><paragraph class="indentUp0 fontsize10" id="y7f5d3068-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="6">“(6) </num><content>taking such steps as may be necessary to ensure the suicide prevention hotline is protected from cybersecurity incidents and eliminates known cybersecurity vulnerabilities.”</content></paragraph>
</quotedContent>.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f5d5779-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s108/b" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Reporting</inline>.—</heading><chapeau>Section 520E–3 of the Public Health Service Act (<ref href="/us/usc/t42/s290bb–36c">42 U.S.C. 290bb–36c</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f5d577a-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s108/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> subsection (f) as subsection (g); and</content></paragraph>
<paragraph class="fontsize10" id="y7f5d577b-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s108/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="insert">inserting</amendingAction> after subsection (e) the following:<quotedContent><subsection class="indentDown1 firstIndent0 fontsize10" id="y7f5da59c-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="f">“(f) </num><heading class="fontsize10"><inline class="smallCaps">Cybersecurity Reporting</inline>.—</heading><paragraph class="fontsize10" id="y7f5da59d-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><heading class="fontsize10"><inline class="smallCaps">Notification</inline>.—</heading><subparagraph class="fontsize10" id="y7f5da59e-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><heading class="fontsize10"><inline class="smallCaps">In general</inline>.—</heading><chapeau>The program’s network administrator receiving Federal funding pursuant to subsection (a) shall report to the Assistant Secretary, in a manner that protects personal privacy, consistent with applicable Federal and State privacy laws—</chapeau><clause class="fontsize10" id="y7f5da59f-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">“(i) </num><content>any identified cybersecurity vulnerabilities to the program within a reasonable amount of time after identification of such a vulnerability; and</content></clause>
<clause class="fontsize10" id="y7f5da5a0-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">“(ii) </num><content>any identified cybersecurity incidents to the program within a reasonable amount of time after identification of such incident.</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="y7f5da5a1-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><heading class="fontsize10"><inline class="smallCaps">Local and regional crisis centers</inline>.—</heading><chapeau>Local and regional crisis centers participating in the program shall report to the program’s network administrator identified under subparagraph (A), in a manner that protects personal privacy, consistent with applicable Federal and State privacy laws—</chapeau><clause class="fontsize10" id="y7f5da5a2-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">“(i) </num><content>any identified cybersecurity vulnerabilities to the program within a reasonable amount of time after identification of such vulnerability; and</content></clause>
<clause class="fontsize10" id="y7f5da5a3-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">“(ii) </num><content>any identified cybersecurity incidents to the program within a reasonable amount of time after identification of such incident.</content></clause>
</subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f5da5a4-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><heading class="fontsize10"><inline class="smallCaps">Notification</inline>.—</heading><content>If the program’s network administrator receiving funding pursuant to subsection (a) discovers, or is informed by a local or regional crisis center pursuant to paragraph (1)(B) of, a cybersecurity vulnerability or incident, within a reasonable amount of time after such discovery or receipt of information, such entity shall report the vulnerability or incident to the Assistant Secretary.</content></paragraph>
<paragraph class="fontsize10" id="y7f5da5a5-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">“(3) </num><heading class="fontsize10"><inline class="smallCaps">Clarification</inline>.—</heading><subparagraph class="fontsize10" id="y7f5dccb6-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><heading class="fontsize10"><inline class="smallCaps">Oversight</inline>.—</heading><clause class="fontsize10" id="y7f5dccb7-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">“(i) </num><heading class="fontsize10"><inline class="smallCaps">Local and regional crisis centers</inline>.—</heading><content>Except as provided in clause (ii), local and regional crisis centers participating in the program shall oversee all technology each center employs in the provision of services as a participant in the program.</content></clause>
<clause class="fontsize10" id="y7f5dccb8-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">“(ii) </num><heading class="fontsize10"><inline class="smallCaps">Network administrator</inline>.—</heading><content>The program’s network administrator receiving Federal funding pursuant to subsection (a) shall oversee the technology each crisis center employs in the provision of services as a participant in the program if such oversight responsibilities are established in the applicable network participation agreement.<page identifier="/us/stat/139/677">139 STAT. 677</page></content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="y7f5dccb9-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><heading class="fontsize10"><inline class="smallCaps">Supplement, not supplant</inline>.—</heading><content>The cybersecurity incident reporting requirements under this subsection shall supplement, and not supplant, cybersecurity incident reporting requirements under other provisions of applicable Federal law that are in effect on the date of the enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2025.”</content></subparagraph>
</paragraph>
</subsection>
</quotedContent>.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f5dccba-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s108/c" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">(c) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5dccbb-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Deadline.</p></sidenote><heading class="fontsize10"><inline class="smallCaps">Study</inline>.—</heading><chapeau>Not later than 180 days after the date of the enactment of this Act, the Comptroller General of the United States shall—</chapeau><paragraph class="fontsize10" id="y7f5dccbc-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s108/c/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5dccbd-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Evaluation.</p></sidenote>conduct and complete a study that evaluates cybersecurity risks and vulnerabilities associated with the 9–8–8 National Suicide Prevention Lifeline; and</content></paragraph>
<paragraph class="fontsize10" id="y7f5dccbe-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s108/c/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5dccbf-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Reports.</p></sidenote><content>submit a report on the findings of such study to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives.</content></paragraph>
</subsection>
</section>
<section id="d3755e1604" identifier="/us/pl/119/44/tI/s109" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="109">SEC. 109. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5dccc0-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><heading>MONITORING AND REPORTING OF CHILD, YOUTH, AND ADULT TRAUMA.</heading><content style="-uslm-lc:I658120"> Section 7131(e) of the SUPPORT for Patients and Communities Act (<ref href="/us/usc/t42/s242t/e">42 U.S.C. 242t(e)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> “<quotedText>$2,000,000 for each of fiscal years 2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$9,000,000 for each of fiscal years 2026 through 2030</quotedText>”.</content></section>
<section id="d3755e1626" identifier="/us/pl/119/44/tI/s110" style="-uslm-lc:I658143"><num class="fontsize12" value="110">SEC. 110. </num><heading>BRUCE’S LAW.</heading><subsection class="firstIndent0 fontsize10" id="y7f5e6901-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s110/a" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">Youth Prevention and Recovery</inline>.—</heading><chapeau>Section 7102(c) of the SUPPORT for Patients and Communities Act (<ref href="/us/usc/t42/s290bb–7a/c">42 U.S.C. 290bb–7a(c)</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f5e6902-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s110/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in paragraph (3)(A)(i), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>, which may include strategies to increase education and awareness of the potency and dangers of synthetic opioids (including drugs contaminated with fentanyl) and, as appropriate, other emerging drug use or misuse issues</quotedText>” before the semicolon; and</content></paragraph>
<paragraph class="fontsize10" id="y7f5e6903-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s110/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>in paragraph (4)(A), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>and strategies to increase education and awareness of the potency and dangers of synthetic opioids (including drugs contaminated with fentanyl) and, as appropriate, emerging drug use or misuse issues</quotedText>” before the semicolon.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f5e6904-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s110/b" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Interdepartmental Substance Use Disorders Coordinating Committee</inline>.—</heading><chapeau>Section 7022 of the SUPPORT for Patients and Communities Act (<ref href="/us/usc/t42/s290aa">42 U.S.C. 290aa note</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f5e6905-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s110/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>by <amendingAction type="delete">striking</amendingAction> subsection (g) and <amendingAction type="insert">inserting</amendingAction> the following:<quotedContent><subsection class="indentDown1 firstIndent0 fontsize10" id="y7f5eb726-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="g">“(g) </num><heading class="fontsize10"><inline class="smallCaps">Working Groups</inline>.—</heading><paragraph class="fontsize10" id="y7f5eb727-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5eb728-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Establishment.</p></sidenote><inline class="smallCaps">In general</inline>.—</heading><content>The Committee may establish working groups for purposes of carrying out the duties described in subsection (e). Any such working group shall be composed of members of the Committee (or the designees of such members) and may hold such meetings as are necessary to carry out the duties delegated to the working group.</content></paragraph>
<paragraph class="fontsize10" id="y7f5eb729-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><heading class="fontsize10"><inline class="smallCaps">Additional federal interagency work group on fentanyl contamination of illegal drugs</inline>.—</heading><subparagraph class="fontsize10" id="y7f5eb72a-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><heading class="fontsize10"><inline class="smallCaps">Establishment</inline>.—</heading><content>The Secretary, acting through the Committee, shall establish a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs (referred to in this paragraph as the ‘Work Group’) consisting of representatives from relevant Federal departments and agencies on the Committee.<page identifier="/us/stat/139/678">139 STAT. 678</page></content></subparagraph>
<subparagraph class="fontsize10" id="y7f5ede3b-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><heading class="fontsize10"><inline class="smallCaps">Consultation</inline>.—</heading><chapeau>The Work Group shall consult with relevant stakeholders and subject matter experts, including—</chapeau><clause class="fontsize10" id="y7f5ede3c-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">“(i) </num><content>State, Tribal, and local subject matter experts in reducing, preventing, and responding to drug overdose caused by fentanyl contamination of illicit drugs; and</content></clause>
<clause class="fontsize10" id="y7f5ede3d-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">“(ii) </num><content>family members of both adults and youth who have overdosed by fentanyl contaminated illicit drugs.</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="y7f5ede3e-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">“(C) </num><heading class="fontsize10"><inline class="smallCaps">Duties</inline>.—</heading><chapeau>The Work Group shall—</chapeau><clause class="fontsize10" id="y7f5ede3f-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">“(i) </num><content>examine Federal efforts to reduce and prevent drug overdose by fentanyl-contaminated illicit drugs;</content></clause>
<clause class="fontsize10" id="y7f5ede40-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">“(ii) </num><content>identify strategies to improve State, Tribal, and local responses to overdose by fentanyl-contaminated illicit drugs;</content></clause>
<clause class="fontsize10" id="y7f5ede41-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="iii">“(iii) </num><content>coordinate with the Secretary, as appropriate, in carrying out activities to raise public awareness of synthetic opioids and other emerging drug use and misuse issues;</content></clause>
<clause class="fontsize10" id="y7f5ede42-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="iv">“(iv) </num><content>make recommendations to Congress for improving Federal programs, including with respect to the coordination of efforts across such programs; and</content></clause>
<clause class="fontsize10" id="y7f5ede43-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="v">“(v) </num><content>make recommendations for educating youth on the potency and dangers of drugs contaminated by fentanyl.</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="y7f5ede44-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">“(D) </num><heading class="fontsize10"><inline class="smallCaps">Annual report to secretary</inline>.—</heading><content>The Work Group shall annually prepare and submit to the Secretary, the Committee on Health, Education, Labor, and Pensions of the Senate, and the Committee on Energy and Commerce and the Committee on Education and Workforce of the House of Representatives, a report on the activities carried out by the Work Group under subparagraph (C), including recommendations to reduce and prevent drug overdose by fentanyl contamination of illegal drugs, in all populations, and specifically among youth at risk for substance misuse.”</content></subparagraph>
</paragraph>
</subsection>
</quotedContent>; and</content></paragraph>
<paragraph class="fontsize10" id="y7f5ede45-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s110/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="delete">striking</amendingAction> subsection (i) and <amendingAction type="insert">inserting</amendingAction> the following:<quotedContent><clause class="indentDown1 firstIndent0 fontsize10" id="y7f5ede46-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">“(i) </num><heading class="fontsize10"><inline class="smallCaps">Sunset</inline>.—</heading><content>The Committee shall terminate on September 30, 2030.”</content></clause>
</quotedContent>.</content></paragraph>
</subsection>
</section>
<section id="d3755e1822" identifier="/us/pl/119/44/tI/s111" style="-uslm-lc:I658143"><num class="fontsize12" value="111">SEC. 111. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5ede47-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180"><ref href="/us/usc/t21/s822a">21 USC 822a note</ref>.</p></sidenote><heading>GUIDANCE ON AT-HOME DRUG DISPOSAL SYSTEMS.</heading><subsection class="firstIndent0 fontsize10" id="y7f5f2c68-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s111/a" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5f2c69-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Deadline.</p><p class="leftAlign firstIndent0 fontsize8" id="x7f5f2c6a-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Publication.</p></sidenote><inline class="smallCaps">In General</inline>.—</heading><content>Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services, in consultation with the Administrator of the Drug Enforcement Administration, shall publish guidance to facilitate the use of at-home safe disposal systems for applicable drugs.</content></subsection>
<subsection class="firstIndent0 fontsize10" id="y7f5f2c6b-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s111/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5f537c-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Recommenda-</p><p class="leftAlign firstIndent0 fontsize8" id="x7f5f537d-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">tions.</p><p class="leftAlign firstIndent0 fontsize8" id="x7f5f537e-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Standards.</p></sidenote><inline class="smallCaps">Contents</inline>.—</heading><chapeau>The guidance under subsection (a) shall include—</chapeau><paragraph class="fontsize10" id="y7f5f537f-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s111/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>recommended standards for effective at-home drug disposal systems to meet applicable requirements enforced by the Food and Drug Administration;</content></paragraph>
<paragraph class="fontsize10" id="y7f5f5380-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s111/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>recommended information to include as instructions for use to disseminate with at-home drug disposal systems;</content></paragraph>
<paragraph class="fontsize10" id="y7f5f5381-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s111/b/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>best practices and educational tools to support the use of an at-home drug disposal system, as appropriate; and<page identifier="/us/stat/139/679">139 STAT. 679</page></content></paragraph>
<paragraph class="fontsize10" id="y7f5f5382-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s111/b/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><content>recommended use of licensed health providers for the dissemination of education, instruction, and at-home drug disposal systems, as appropriate.</content></paragraph>
</subsection>
</section>
<section id="d3755e1885" identifier="/us/pl/119/44/tI/s112" style="-uslm-lc:I658143"><num class="fontsize12" value="112">SEC. 112. </num><heading>ASSESSMENT OF OPIOID DRUGS AND ACTIONS.</heading><subsection class="firstIndent0 fontsize10" id="y7f5fa1a3-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s112/a" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5fa1a4-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Web posting.</p><p class="leftAlign firstIndent0 fontsize8" id="x7f5fa1a5-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Reports.</p></sidenote><inline class="smallCaps">In General</inline>.—</heading><chapeau>Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the “Secretary”) shall publish on the website of the Food and Drug Administration (referred to in this section as the “FDA”) a report that outlines a plan for assessing opioid analgesic drugs that are approved under section 505 of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/t21/s355">21 U.S.C. 355</ref>) that addresses the public health effects of such opioid analgesic drugs as part of the benefit-risk assessment and the activities of the FDA that relate to facilitating the development of nonaddictive medical products intended to treat pain or addiction. Such report shall include—</chapeau><paragraph class="fontsize10" id="y7f5fa1a6-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s112/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>an update on the actions taken by the FDA to consider the effectiveness, safety, benefit-risk profile, and use of approved opioid analgesic drugs;</content></paragraph>
<paragraph class="fontsize10" id="y7f5fa1a7-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s112/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>a timeline for an assessment of the potential need, as appropriate, for labeling changes, revised or additional postmarketing requirements, enforcement actions, or withdrawals for opioid analgesic drugs;</content></paragraph>
<paragraph class="fontsize10" id="y7f5fa1a8-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s112/a/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>an overview of the steps that the FDA has taken to support the development and approval of nonaddictive medical products intended to treat pain or addiction, and actions planned to further support the development and approval of such products; and</content></paragraph>
<paragraph class="fontsize10" id="y7f5fa1a9-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s112/a/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><content>an overview of the consideration by the FDA of clinical trial methodologies for analgesic drugs, including the enriched enrollment randomized withdrawal methodology, and the benefits and drawbacks associated with different trial methodologies for such drugs, incorporating any public input received under subsection (b).</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f5fa1aa-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tI/s112/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Public Input</inline>.—</heading><content>In carrying out subsection (a), the Secretary shall provide an opportunity for public input concerning the regulation by the FDA of opioid analgesic drugs, including scientific evidence that relates to conditions of use, safety, or benefit-risk assessment (including consideration of the public health effects) of such opioid analgesic drugs.</content></subsection>
</section>
<section id="d3755e1937" identifier="/us/pl/119/44/tI/s113" style="-uslm-lc:I658143"><num class="fontsize12" value="113">SEC. 113. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f5fc8bb-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180"><ref href="/us/usc/t42/s290ee–3a">42 USC 290ee–3a note</ref>.</p></sidenote><heading>GRANT PROGRAM FOR STATE AND TRIBAL RESPONSE TO OPIOID USE DISORDERS.</heading><content style="-uslm-lc:I658120"> The activities carried out pursuant to section 1003(b)(4)(A) of the 21st Century Cures Act (<ref href="/us/usc/t42/s290ee–3a/b/4/A">42 U.S.C. 290ee–3a(b)(4)(A)</ref>) may include facilitating access to products used to prevent overdose deaths by detecting the presence of one or more substances, such as fentanyl and xylazine test strips, to the extent the purchase and possession of such products is consistent with Federal and State law.<page identifier="/us/stat/139/680">139 STAT. 680</page></content></section>
<num value="II">TITLE II—</num><heading>TREATMENT</heading>
<section id="d3755e1960" identifier="/us/pl/119/44/tII/s201" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="201">SEC. 201. </num><heading>RESIDENTIAL TREATMENT PROGRAM FOR PREGNANT AND POSTPARTUM WOMEN.</heading><chapeau class="indentUp0 firstIndent0 fontsize10" id="x7f6016dc-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"> Section 508 of the Public Health Service Act (<ref href="/us/usc/t42/s290bb–1">42 U.S.C. 290bb–1</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f6016dd-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s201/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in subsection (d)(11)(C), by <amendingAction type="delete">striking</amendingAction> “<quotedText>providing health services</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>providing health care services</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="y7f6016de-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s201/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in subsection (g)—</chapeau><subparagraph class="fontsize10" id="y7f6016df-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s201/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>a plan describing</quotedText>” after “<quotedText>will provide</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f6016e0-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s201/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="add">adding</amendingAction> at the end the following: “<quotedText>Such plan may include a description of how such applicant will target outreach to women disproportionately impacted by maternal substance use disorder.</quotedText>”; and</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f6016e1-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s201/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f6016e2-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><content>in subsection (s), by <amendingAction type="delete">striking</amendingAction> “<quotedText>$29,931,000 for each of fiscal years 2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$38,931,000 for each of fiscal years 2026 through 2030</quotedText>”.</content></paragraph>
</section>
<section id="d3755e2023" identifier="/us/pl/119/44/tII/s202" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="202">SEC. 202. </num><heading>IMPROVING ACCESS TO ADDICTION MEDICINE PROVIDERS.</heading><chapeau class="indentUp0 firstIndent0 fontsize10" id="x7f603df3-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"> Section 597 of the Public Health Service Act (<ref href="/us/usc/t42/s290ll">42 U.S.C. 290ll</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f603df4-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s202/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in subsection (a)(1), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>diagnosis,</quotedText>” after “<quotedText>related to</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="y7f603df5-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s202/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>in subsection (b), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>addiction medicine,</quotedText>” after “<quotedText>psychiatry,</quotedText>”.</content></paragraph>
</section>
<section id="d3755e2054" identifier="/us/pl/119/44/tII/s203" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="203">SEC. 203. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f603df6-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><heading>MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING GRANTS.</heading><content style="-uslm-lc:I658120"> Section 756(f) of the Public Health Service Act (<ref href="/us/usc/t42/s294e–1/f">42 U.S.C. 294e–1(f)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> “<quotedText>fiscal years 2023 through 2027</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>fiscal years 2026 through 2030</quotedText>”.</content></section>
<section id="d3755e2076" identifier="/us/pl/119/44/tII/s204" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="204">SEC. 204. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f606507-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><heading>LOAN REPAYMENT PROGRAM FOR SUBSTANCE USE DISORDER TREATMENT WORKFORCE.</heading><content style="-uslm-lc:I658120"> Section 781(j) of the Public Health Service Act (<ref href="/us/usc/t42/s295h/j">42 U.S.C. 295h(j)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> “<quotedText>$25,000,000 for each of fiscal years 2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$40,000,000 for each of fiscal years 2026 through 2030</quotedText>”.</content></section>
<section id="d3755e2099" identifier="/us/pl/119/44/tII/s205" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="205">SEC. 205. </num><heading>DEVELOPMENT AND DISSEMINATION OF MODEL TRAINING PROGRAMS FOR SUBSTANCE USE DISORDER PATIENT RECORDS.</heading><content style="-uslm-lc:I658120"> Section 7053 of the SUPPORT for Patients and Communities Act (<ref href="/us/usc/t42/s290dd–2">42 U.S.C. 290dd–2 note</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> subsection (e).</content></section>
<section id="d3755e2115" identifier="/us/pl/119/44/tII/s206" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="206">SEC. 206. </num><heading>TASK FORCE ON BEST PRACTICES FOR TRAUMA-INFORMED IDENTIFICATION, REFERRAL, AND SUPPORT.</heading><chapeau class="indentUp0 firstIndent0 fontsize10" id="x7f60b328-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"> Section 7132 of the SUPPORT for Patients and Communities Act (<ref href="/us/pl/115/271">Public Law 115–271</ref>; <ref href="/us/stat/132/4046">132 Stat. 4046</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f60b329-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s206/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><chapeau>in subsection (b)(1)—</chapeau><subparagraph class="fontsize10" id="y7f60b32a-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s206/1/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> subparagraph (CC) as subparagraph (DD); and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f60b32b-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s206/1/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="insert">inserting</amendingAction> after subparagraph (BB) the following:<quotedContent><subitem class="indentUp0 fontsize10" id="y7f60b32c-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="CC">“(CC) </num><content>The Administration for Community Living.”</content></subitem>
</quotedContent>;<page identifier="/us/stat/139/681">139 STAT. 681</page></content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f60b32d-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s206/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>in subsection (d)(1), in the matter preceding subparagraph (A), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>, developmental disability service providers</quotedText>” before “<quotedText>, individuals who are</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="y7f60b32e-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s206/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>in subsection (i), by <amendingAction type="delete">striking</amendingAction> “<quotedText>2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2030</quotedText>”.</content></paragraph>
</section>
<section id="d3755e2184" identifier="/us/pl/119/44/tII/s207" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="207">SEC. 207. </num><heading>GRANTS TO ENHANCE ACCESS TO SUBSTANCE USE DISORDER TREATMENT.</heading><chapeau class="indentUp0 firstIndent0 fontsize10" id="x7f60da3f-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"> Section 3203 of the SUPPORT for Patients and Communities Act (<ref href="/us/usc/t21/s823">21 U.S.C. 823 note</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f60da40-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s207/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>by <amendingAction type="delete">striking</amendingAction> subsection (b); and</content></paragraph>
<paragraph class="fontsize10" id="y7f610151-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s207/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>(a) <headingText class="smallCaps">In General</headingText>.—The Secretary</quotedText>” and <amendingAction type="insert">inserting</amendingAction> the following: “<quotedText>The Secretary</quotedText>”.</content></paragraph>
</section>
<section id="d3755e2221" identifier="/us/pl/119/44/tII/s208" style="-uslm-lc:I658143"><num class="fontsize12" value="208">SEC. 208. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f610152-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180"><ref href="/us/usc/t42/s300x">42 USC 300x note</ref>.</p></sidenote><heading>STATE GUIDANCE RELATED TO INDIVIDUALS WITH SERIOUS MENTAL ILLNESS AND CHILDREN WITH SERIOUS EMOTIONAL DISTURBANCE.</heading><subsection class="firstIndent0 fontsize10" id="y7f614f73-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s208/a" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f617684-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Deadline.</p></sidenote><heading class="fontsize10"><inline class="smallCaps">Review of Use of Certain Funding</inline>.—</heading><chapeau>Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the “Secretary”), acting through the Assistant Secretary for Mental Health and Substance Use, shall conduct a review of State use of funds made available under the Community Mental Health Services Block Grant program under subpart I of part B of title XIX of the Public Health Service Act (<ref href="/us/usc/t42/s300x/etseq">42 U.S.C. 300x et seq.</ref>) (referred to in this section as the “block grant program”) for first episode psychosis activities. Such review shall consider the following:</chapeau><paragraph class="fontsize10" id="y7f617685-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s208/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>How States use funds for evidence-based treatments and services according to the standard of care for individuals with early serious mental illness and children with a serious emotional disturbance.</content></paragraph>
<paragraph class="fontsize10" id="y7f617686-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s208/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>The percentages of the State funding under the block grant program expended on early serious mental illness and first episode psychosis, and the number of individuals served under such funds.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f617687-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s208/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Report and Guidance</inline>.—</heading><paragraph class="fontsize10" id="y7f617688-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s208/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><heading class="fontsize10"><inline class="smallCaps">Report</inline>.—</heading><chapeau>Not later than 180 days after the completion of the review under subsection (a), the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives a report describing—</chapeau><subparagraph class="fontsize10" id="y7f617689-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s208/b/1/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>the findings of the review under subsection (a); and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f61768a-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s208/b/1/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>any recommendations for changes to the block grant program that would facilitate improved outcomes for individuals with serious mental illness and children with serious emotional disturbance.</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f61768b-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s208/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><heading class="fontsize10"><inline class="smallCaps">Guidance</inline>.—</heading><content>Not later than 1 year after the date on which the report is submitted under paragraph (1), the Secretary shall update the guidance provided to States under the block grant program on coordinated specialty care and other evidence-based mental health care services for individuals with serious mental illness and children with a serious emotional disturbance, based on the findings and recommendations of such report.<page identifier="/us/stat/139/682">139 STAT. 682</page></content></paragraph>
</subsection>
</section>
<section id="d3755e2296" identifier="/us/pl/119/44/tII/s209" style="-uslm-lc:I658143"><num class="fontsize12" value="209">SEC. 209. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f61768c-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180"><ref href="/us/usc/t21/s812">21 USC 812 note</ref>.</p></sidenote><heading>REVIEWING THE SCHEDULING OF APPROVED PRODUCTS CONTAINING A COMBINATION OF BUPRENORPHINE AND NALOXONE.</heading><subsection class="firstIndent0 fontsize10" id="y7f619d9d-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s209/a" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">Secretary of HHS</inline>.—</heading><chapeau>The Secretary of Health and Human Services shall, consistent with the requirements and procedures set forth in sections 201 and 202 of the Controlled Substances Act (<ref href="/us/usc/t21/s811">21 U.S.C. 811</ref>, 812)—</chapeau><paragraph class="fontsize10" id="y7f619d9e-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s209/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>review the relevant data pertaining to the scheduling of products containing a combination of buprenorphine and naloxone that have been approved under section 505 of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/t21/s355">21 U.S.C. 355</ref>); and</content></paragraph>
<paragraph class="fontsize10" id="y7f619d9f-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s209/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f619da0-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Regulations.</p></sidenote><content>if appropriate, request that the Attorney General initiate rulemaking proceedings to revise the schedules accordingly with respect to such products.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f61c4b1-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s209/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Attorney General</inline>.—</heading><content>The Attorney General shall review any request made by the Secretary of Health and Human Services under subsection (a)(2) and determine whether to initiate proceedings to revise the schedules in accordance with the criteria set forth in sections 201 and 202 of the Controlled Substances Act (<ref href="/us/usc/t21/s811">21 U.S.C. 811</ref>, 812).</content></subsection>
</section>
<section id="d3755e2349" identifier="/us/pl/119/44/tII/s210" style="-uslm-lc:I658143"><num class="fontsize12" value="210">SEC. 210. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f61c4b2-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180"><ref href="/us/usc/t42/s290ee">42 USC 290ee note</ref>.</p></sidenote><heading>REFERENCES TO OPIOID OVERDOSE REVERSAL AGENTS IN HHS GRANT PROGRAMS.</heading><subsection class="firstIndent0 fontsize10" id="y7f6212d3-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s210/a" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">In General</inline>.—</heading><content>The Secretary of Health and Human Services shall ensure that, as appropriate, whenever the Department of Health and Human Services issues a regulation or guidance for any grant program addressing opioid misuse and use disorders, any reference to an opioid overdose reversal drug (such as a reference to naloxone) is inclusive of any opioid overdose reversal drug that has been approved under section 505 of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/t21/s355">21 U.S.C. 355</ref>) for emergency treatment of a known or suspected opioid overdose.</content></subsection>
<subsection class="firstIndent0 fontsize10" id="y7f6212d4-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s210/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Existing References</inline>.—</heading><paragraph class="fontsize10" id="y7f6212d5-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s210/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f6212d6-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Deadline.</p></sidenote><inline class="smallCaps">Update</inline>.—</heading><content>Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services shall update all references described in paragraph (2) to be inclusive of any opioid overdose reversal drug that has been approved or otherwise authorized for use by the Food and Drug Administration.</content></paragraph>
<paragraph class="fontsize10" id="y7f6212d7-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s210/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><heading class="fontsize10"><inline class="smallCaps">References</inline>.—</heading><chapeau>A reference described in this paragraph is any reference to an opioid overdose reversal drug (such as naloxone) in any regulation or guidance of the Department of Health and Human Services that—</chapeau><subparagraph class="fontsize10" id="y7f6212d8-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s210/b/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>was issued before the date of enactment of this Act; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f6212d9-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s210/b/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><chapeau>is included in—</chapeau><clause class="fontsize10" id="y7f6212da-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s210/b/2/B/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content>the grant program for State and Tribal response to opioid use disorders under section 1003 of the 21st Century Cures Act (<ref href="/us/usc/t42/s290ee–3">42 U.S.C. 290ee–3 note</ref>) (commonly referred to as “State Opioid Response Grants” and “Tribal Opioid Response Grants”); or</content></clause>
<clause class="fontsize10" id="y7f6212db-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s210/b/2/B/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>the grant program for priority substance use disorder prevention needs of regional and national significance under section 516 of the Public Health Service Act (<ref href="/us/usc/t42/s290bb–22">42 U.S.C. 290bb–22</ref>).<page identifier="/us/stat/139/683">139 STAT. 683</page></content></clause>
</subparagraph>
</paragraph>
</subsection>
</section>
<section id="d3755e2432" identifier="/us/pl/119/44/tII/s211" style="-uslm-lc:I658143"><num class="fontsize12" value="211">SEC. 211. </num><heading>ROUNDTABLE ON USING HEALTH INFORMATION TECHNOLOGY TO IMPROVE MENTAL HEALTH AND SUBSTANCE USE CARE OUTCOMES.</heading><subsection class="firstIndent0 fontsize10" id="y7f62d62c-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/a" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f62fd3d-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Deadline.</p><p class="leftAlign firstIndent0 fontsize8" id="x7f62fd3e-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Public information.</p><p class="leftAlign firstIndent0 fontsize8" id="x7f62fd3f-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Examination.</p></sidenote><inline class="smallCaps">Roundtable</inline>.—</heading><chapeau>Not later than 180 days after the date of enactment of this Act, the National Coordinator for Health Information Technology shall convene a public roundtable to examine—</chapeau><paragraph class="fontsize10" id="y7f62fd40-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>how the expanded use of electronic health records among mental health and substance use service providers can improve outcomes for patients in mental health and substance use settings; and</content></paragraph>
<paragraph class="fontsize10" id="y7f62fd41-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>how best to increase electronic health record adoption among such providers.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f62fd42-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Participants</inline>.—</heading><content>The National Coordinator for Health Information Technology shall ensure that the participants in the roundtable under subsection (a) include private and public sector stakeholders, including patients, providers (including providers of inpatient services and providers of outpatient services), and representatives of payors, health information exchanges, professional associations, health information technology vendors, health information technology certification organizations, and State and Federal agencies.</content></subsection>
<subsection class="firstIndent0 fontsize10" id="y7f62fd43-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">(c) </num><heading class="fontsize10"><inline class="smallCaps">Report</inline>.—</heading><chapeau>Not later than 180 days after the conclusion of the public stakeholder roundtable under subsection (a), the National Coordinator for Health Information Technology shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report outlining information gathered from the roundtable under subsection (a). Such report shall include an examination of—</chapeau><paragraph class="fontsize10" id="y7f62fd44-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>recommendations from the roundtable participants;</content></paragraph>
<paragraph class="fontsize10" id="y7f62fd45-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>unique considerations for using electronic health record systems in mental health and substance use treatment settings;</content></paragraph>
<paragraph class="fontsize10" id="y7f62fd46-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>unique considerations for developers of health information technology relating to certification of electronic health record systems for use in mental health and substance use treatment settings where the applicable health information technology is not subject to certification requirements;</content></paragraph>
<paragraph class="fontsize10" id="y7f62fd47-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><content>current usage of electronic health record systems by mental health and substance use disorder service providers, and the scope and magnitude of such providers that do not use electronic health record systems;</content></paragraph>
<paragraph class="fontsize10" id="y7f62fd48-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/5" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="5">(5) </num><content>examples of how electronic health record systems enable coordinated care and care management;</content></paragraph>
<paragraph class="fontsize10" id="y7f62fd49-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/6" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="6">(6) </num><content>how electronic health record systems advance appropriate patient and provider access to secure, usable electronic information exchange;</content></paragraph>
<paragraph class="fontsize10" id="y7f62fd4a-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/7" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="7">(7) </num><content>how electronic health record systems can be connected to or support existing systems, which may include the 9–8–8 National Suicide Prevention Lifeline, mobile crisis response systems, and co-responder programs, to facilitate connectivity, response, and integrated care;</content></paragraph>
<paragraph class="fontsize10" id="y7f62fd4b-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/8" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="8">(8) </num><content>any existing programs to support greater adoption of electronic health record systems among mental health and substance use service providers;</content></paragraph>
<paragraph class="fontsize10" id="y7f62fd4c-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/9" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="9">(9) </num><content>any limitations to greater adoption of electronic health record systems among mental health and substance use service providers;<page identifier="/us/stat/139/684">139 STAT. 684</page></content></paragraph>
<paragraph class="fontsize10" id="y7f62fd4d-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/10" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="10">(10) </num><content>the costs of adoption of electronic health record systems by mental health and substance use disorder service providers; and</content></paragraph>
<paragraph class="fontsize10" id="y7f62fd4e-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tII/s211/c/11" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="11">(11) </num><content>best practices implemented by States and other entities to support adoption of use of electronic health records among mental health and substance use disorder service providers.</content></paragraph>
</subsection>
</section>
<num value="III">TITLE III—</num><heading>RECOVERY</heading>
<section id="d3755e2548" identifier="/us/pl/119/44/tIII/s301" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="301">SEC. 301. </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f62fd4f-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><heading>BUILDING COMMUNITIES OF RECOVERY.</heading><content style="-uslm-lc:I658120"> Section 547(f) of the Public Health Service Act (<ref href="/us/usc/t42/s290ee–2/f">42 U.S.C. 290ee–2(f)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> “<quotedText>$5,000,000 for each of fiscal years 2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$17,000,000 for each of fiscal years 2026 through 2030</quotedText>”.</content></section>
<section id="d3755e2570" identifier="/us/pl/119/44/tIII/s302" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="302">SEC. 302. </num><heading>PEER SUPPORT TECHNICAL ASSISTANCE CENTER.</heading><chapeau class="indentUp0 firstIndent0 fontsize10" id="x7f637180-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"> Section 547A of the Public Health Service Act (<ref href="/us/usc/t42/s290ee–2a">42 U.S.C. 290ee–2a</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f637181-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s302/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in subsection (b)(4), by <amendingAction type="delete">striking</amendingAction> “<quotedText>building; and</quotedText>” and <amendingAction type="insert">inserting</amendingAction> the following: <quotedContent>“building, such as—<subparagraph class="fontsize10" id="y7f637182-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>professional development of peer support specialists; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f637183-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><content>making recovery support services available in nonclinical settings; and”</content></subparagraph>
</quotedContent>;</content></paragraph>
<paragraph class="fontsize10" id="y7f637184-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s302/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> subsections (d) and (e) as subsections (e) and (f), respectively;</content></paragraph>
<paragraph class="fontsize10" id="y7f637185-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s302/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>by <amendingAction type="insert">inserting</amendingAction> after subsection (c) the following:<quotedContent><subsection class="indentDown1 firstIndent0 fontsize10" id="y7f63bfa6-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="d">“(d) </num><heading class="fontsize10"><inline class="smallCaps">Regional Centers</inline>.—</heading><paragraph class="fontsize10" id="y7f63bfa7-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f63bfa8-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Establishment.</p></sidenote><inline class="smallCaps">In general</inline>.—</heading><content>The Secretary may establish one regional technical assistance center (referred to in this subsection as the ‘Regional Center’), with existing resources, to assist the Center in carrying out activities described in subsection (b) within the geographic region of such Regional Center in a manner that is tailored to the needs of such region.</content></paragraph>
<paragraph class="fontsize10" id="y7f63bfa9-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f63bfaa-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Reports.</p></sidenote><heading class="fontsize10"><inline class="smallCaps">Evaluation</inline>.—</heading><chapeau>Not later than 4 years after the date of enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2025, the Secretary shall evaluate the activities of the Regional Center and submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the findings of such evaluation, including—</chapeau><subparagraph class="fontsize10" id="y7f63bfab-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>a description of the distinct roles and responsibilities of the Regional Center and the Center;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f63bfac-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><content>available information relating to the outcomes of the Regional Center under this subsection, such as any impact on the operations and efficiency of the Center relating to requests for technical assistance and support within the region of such Regional Center;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f63bfad-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">“(C) </num><content>a description of any gaps or areas of duplication relating to the activities of the Regional Center and the Center within such region; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f63bfae-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">“(D) </num><content>recommendations relating to the modification, expansion, or termination of the Regional Center under this subsection.<page identifier="/us/stat/139/685">139 STAT. 685</page></content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f63bfaf-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">“(3) </num><heading class="fontsize10"><inline class="smallCaps">Termination</inline>.—</heading><content>This subsection shall terminate on September 30, 2030.”</content></paragraph>
</subsection>
</quotedContent>; and</content></paragraph>
<paragraph class="fontsize10" id="y7f63bfb0-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s302/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f63bfb1-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><content>in subsection (f), as so redesignated, by <amendingAction type="delete">striking</amendingAction> “<quotedText>$1,000,000 for each of fiscal years 2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$2,000,000 for each of fiscal years 2026 through 2030</quotedText>”.</content></paragraph>
</section>
<section id="d3755e2707" identifier="/us/pl/119/44/tIII/s303" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="303">SEC. 303. </num><heading>COMPREHENSIVE OPIOID RECOVERY CENTERS.</heading><chapeau class="indentUp0 firstIndent0 fontsize10" id="x7f6434e2-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"> Section 552 of the Public Health Service Act (<ref href="/us/usc/t42/s290ee–7">42 U.S.C. 290ee–7</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f6434e3-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s303/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><chapeau>in subsection (d)(2)—</chapeau><subparagraph class="fontsize10" id="y7f6434e4-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s303/1/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in the matter preceding subparagraph (A), by <amendingAction type="delete">striking</amendingAction> “<quotedText>and in such manner</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>, in such manner, and containing such information and assurances, including relevant documentation,</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f6434e5-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s303/1/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in subparagraph (A), by <amendingAction type="delete">striking</amendingAction> “<quotedText>is capable of coordinating with other entities to carry out</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>has the demonstrated capability to carry out, through referral or contractual arrangements</quotedText>”;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f6434e6-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s303/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in subsection (h)—</chapeau><subparagraph class="fontsize10" id="y7f6434e7-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s303/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> paragraphs (1) through (4) as subparagraphs (A) through (D), respectively, and adjusting the margins accordingly;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f6434e8-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s303/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>With respect to</quotedText>” and <amendingAction type="insert">inserting</amendingAction> the following:<quotedContent><paragraph class="indentDown1 fontsize10" id="y7f6434e9-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><heading class="fontsize10"><inline class="smallCaps">In general</inline>.—</heading><content>With respect to”</content></paragraph>
</quotedContent>; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f6434ea-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s303/2/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><content>by <amendingAction type="add">adding</amendingAction> at the end the following:<quotedContent><paragraph class="indentDown1 fontsize10" id="y7f645bfb-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><heading class="fontsize10"><inline class="smallCaps">Additional reporting for certain eligible entities</inline>.—</heading><content>An entity carrying out activities described in subsection (g) through referral or contractual arrangements shall include in the submissions required under paragraph (1) information related to the status of such referrals or contractual arrangements, including an assessment of whether such referrals or contractual arrangements are supporting the ability of such entity to carry out such activities.”</content></paragraph>
</quotedContent>; and</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f645bfc-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s303/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>in subsection (j), by <amendingAction type="delete">striking</amendingAction> “<quotedText>2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2026 through 2030</quotedText>”.</content></paragraph>
</section>
<section id="d3755e2818" identifier="/us/pl/119/44/tIII/s304" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="304">SEC. 304. </num><heading>YOUTH PREVENTION AND RECOVERY.</heading><chapeau class="indentUp0 firstIndent0 fontsize10" id="x7f65465d-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"> Section 7102(c) of the SUPPORT for Patients and Communities Act (<ref href="/us/usc/t42/s290bb–7a/c">42 U.S.C. 290bb–7a(c)</ref>) (as amended by section 110(a)) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f65465e-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><chapeau>in paragraph (2)—</chapeau><subparagraph class="fontsize10" id="y7f65465f-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/1/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><chapeau>in subparagraph (A)—</chapeau><clause class="fontsize10" id="y7f654660-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/1/A/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><chapeau>in clause (i)—</chapeau><subclause class="fontsize10" id="y7f654661-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/1/A/i/I" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">(I) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>, or a consortium of local educational agencies,</quotedText>” after “<quotedText>a local educational agency</quotedText>”; and</content></subclause>
<subclause class="fontsize10" id="y7f654662-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/1/A/i/II" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">(II) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>high schools</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>secondary schools</quotedText>”; and</content></subclause>
</clause>
<clause class="fontsize10" id="y7f654663-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/1/A/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>in clause (vi), by <amendingAction type="delete">striking</amendingAction> “<quotedText>tribe, or tribal</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>Tribe, or Tribal</quotedText>”;</content></clause>
</subparagraph>
<subparagraph class="fontsize10" id="y7f654664-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/1/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="amend">amending</amendingAction> subparagraph (E) to read as follows:<quotedContent><subparagraph class="indentUp0 fontsize10" id="y7f654665-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="E">“(E) </num><heading class="fontsize10"><inline class="smallCaps">Indian tribe; tribal organization</inline>.—</heading><content>The terms ‘Indian Tribe’ and ‘Tribal organization’ have the meanings given such terms in section 4 of the Indian Self-Determination and Education Assistance Act (<ref href="/us/usc/t25/s5304">25 U.S.C. 5304</ref>).”</content></subparagraph>
</quotedContent>;<page identifier="/us/stat/139/686">139 STAT. 686</page></content></subparagraph>
<subparagraph class="fontsize10" id="y7f654666-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/1/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> subparagraph (K) as subparagraph (L); and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f654667-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/1/D" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">(D) </num><content>by <amendingAction type="insert">inserting</amendingAction> after subparagraph (J) the following:<quotedContent><subparagraph class="indentUp0 fontsize10" id="y7f654668-d532-11f0-b8a8-e1b4a9a7cc9b" role="definitions" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="K">“(K) </num><heading class="fontsize10"><inline class="smallCaps">Secondary school</inline>.—</heading><content>The term ‘<term>secondary school</term>’ has the meaning given such term in section 8101 of the Elementary and Secondary Education Act of 1965 (<ref href="/us/usc/t20/s7801">20 U.S.C. 7801</ref>).”</content></subparagraph>
</quotedContent>;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f656d79-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in paragraph (3)(A), in the matter preceding clause (i)—</chapeau><subparagraph class="fontsize10" id="y7f656d7a-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>and abuse</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f656d7b-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>at increased risk for substance misuse</quotedText>” after “<quotedText>specific populations</quotedText>”;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f656d7c-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><chapeau>in paragraph (4)—</chapeau><subparagraph class="fontsize10" id="y7f656d7d-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/3/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in the matter preceding subparagraph (A), by <amendingAction type="delete">striking</amendingAction> “<quotedText>Indian tribes</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>Indian Tribes</quotedText>”;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f656d7e-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/3/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in subparagraph (A), by <amendingAction type="delete">striking</amendingAction> “<quotedText>and abuse</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f656d7f-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/3/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><content>in subparagraph (B), by <amendingAction type="delete">striking</amendingAction> “<quotedText>peer mentoring</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>peer-to-peer support</quotedText>”;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f656d80-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><content>in paragraph (5), by <amendingAction type="delete">striking</amendingAction> “<quotedText>tribal</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>Tribal</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="y7f656d81-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/5" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="5">(5) </num><chapeau>in paragraph (6)(A)—</chapeau><subparagraph class="fontsize10" id="y7f656d82-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/5/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in clause (iv), by <amendingAction type="delete">striking</amendingAction> “<quotedText>; and</quotedText>” and <amendingAction type="insert">inserting</amendingAction> a semicolon; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f656d83-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/5/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="add">adding</amendingAction> at the end the following:<quotedContent><clause class="fontsize10" id="y7f656d84-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="vi">“(vi) </num><content>a plan to sustain the activities carried out under the grant program, after the grant program has ended; and”</content></clause>
</quotedContent>;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f656d85-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/6" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="6">(6) </num><content>in paragraph (8), by <amendingAction type="delete">striking</amendingAction> “<quotedText>2022</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2028</quotedText>”; and</content></paragraph>
<paragraph class="fontsize10" id="y7f656d86-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s304/7" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="7">(7) </num><content>by <amendingAction type="amend">amending</amendingAction> paragraph (9) to read as follows:<quotedContent><paragraph class="indentUp0 fontsize10" id="y7f659497-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="9">“(9) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f659498-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><heading class="fontsize10"><inline class="smallCaps">Authorization of appropriations</inline>.—</heading><chapeau>To carry out this subsection, there are authorized to be appropriated—</chapeau><subparagraph class="fontsize10" id="y7f659499-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>$10,000,000 for fiscal year 2026;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f65949a-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><content>$12,000,000 for fiscal year 2027;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f65949b-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">“(C) </num><content>$13,000,000 for fiscal year 2028;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f65949c-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">“(D) </num><content>$14,000,000 for fiscal year 2029; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f65949d-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="E">“(E) </num><content>$15,000,000 for fiscal year 2030.”</content></subparagraph>
</paragraph>
</quotedContent>.</content></paragraph>
</section>
<section id="d3755e3107" identifier="/us/pl/119/44/tIII/s305" style="-uslm-lc:I658143"><num class="fontsize12" value="305">SEC. 305. </num><heading>CAREER ACT.</heading><subsection class="firstIndent0 fontsize10" id="y7f67424e-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">In General</inline>.—</heading><chapeau>Section 7183 of the SUPPORT for Patients and Communities Act (<ref href="/us/usc/t42/s290ee–8">42 U.S.C. 290ee–8</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f67424f-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>in the section heading, by <amendingAction type="insert">inserting</amendingAction> “<quotedText>; treatment, recovery, and workforce support grants</quotedText>” after “<quotedText>career act</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="y7f674250-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>in subsection (b), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>each</quotedText>” before “<quotedText>for a period</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="y7f674251-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f674252-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote><chapeau>in subsection (c)—</chapeau><subparagraph class="fontsize10" id="y7f674253-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/3/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in paragraph (1), by <amendingAction type="delete">striking</amendingAction> “<quotedText>the rates described in paragraph (2)</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>the average rates for calendar years 2018 through 2022 described in paragraph (2)</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f674254-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/3/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="amend">amending</amendingAction> paragraph (2) to read as follows:<quotedContent><paragraph class="indentDown1 fontsize10" id="y7f676965-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><heading class="fontsize10"><inline class="smallCaps">Rates</inline>.—</heading><chapeau>The rates described in this paragraph are the following:</chapeau><subparagraph class="fontsize10" id="y7f676966-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>The highest age-adjusted average rates of drug overdose deaths for calendar years 2018 through 2022 based on data from the Centers for Disease Control and <page identifier="/us/stat/139/687">139 STAT. 687</page>
Prevention, including, if necessary, provisional data for calendar year 2022.</content></subparagraph>
<subparagraph class="fontsize10" id="y7f676967-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><content>The highest average rates of unemployment for calendar years 2018 through 2022 based on data provided by the Bureau of Labor Statistics.</content></subparagraph>
<subparagraph class="fontsize10" id="y7f676968-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">“(C) </num><content>The lowest average labor force participation rates for calendar years 2018 through 2022 based on data provided by the Bureau of Labor Statistics.”</content></subparagraph>
</paragraph>
</quotedContent>;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f676969-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/4" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="4">(4) </num><chapeau>in subsection (g)—</chapeau><subparagraph class="fontsize10" id="y7f67696a-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/4/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in each of paragraphs (1) and (3), by <amendingAction type="redesignate">redesignating</amendingAction> subparagraphs (A) and (B) as clauses (i) and (ii), respectively, and adjusting the margins accordingly;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f67696b-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/4/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> paragraphs (1) through (3) as subparagraphs (A) through (C), respectively, and adjusting the margins accordingly;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f67696c-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/4/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><content>in the matter preceding subparagraph (A) (as so redesignated), by <amendingAction type="delete">striking</amendingAction> “<quotedText>An entity</quotedText>” and <amendingAction type="insert">inserting</amendingAction> the following:<quotedContent><paragraph class="indentDown1 fontsize10" id="y7f67696d-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">“(1) </num><heading class="fontsize10"><inline class="smallCaps">In general</inline>.—</heading><content>An entity”</content></paragraph>
</quotedContent>; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f67696e-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/4/D" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">(D) </num><content>by <amendingAction type="add">adding</amendingAction> at the end the following:<quotedContent><paragraph class="indentDown1 fontsize10" id="y7f67907f-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><heading class="fontsize10"><inline class="smallCaps">Transportation services</inline>.—</heading><content>An entity receiving a grant under this section may use not more than 5 percent of the funds for providing transportation for individuals to participate in an activity supported by a grant under this section, which transportation shall be to or from a place of work or a place where the individual is receiving vocational education or job training services or receiving services directly linked to treatment of or recovery from a substance use disorder.</content></paragraph>
<paragraph class="indentDown1 fontsize10" id="y7f679080-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">“(3) </num><heading class="fontsize10"><inline class="smallCaps">Limitation</inline>.—</heading><content>The Secretary may not require an entity to, or give priority to an entity that plans to, use the funds of a grant under this section for activities that are not specified in this subsection.”</content></paragraph>
</quotedContent>;</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f679081-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/5" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="5">(5) </num><content>in subsection (i)(2), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>, which shall include employment and earnings outcomes described in subclauses (I) and (III) of section 116(b)(2)(A)(i) of the Workforce Innovation and Opportunity Act (<ref href="/us/usc/t29/s3141/b/2/A/i">29 U.S.C. 3141(b)(2)(A)(i)</ref>) with respect to the participation of such individuals with a substance use disorder in programs and activities funded by the grant under this section</quotedText>” after “<quotedText>subsection (g)</quotedText>”;</content></paragraph>
<paragraph class="fontsize10" id="y7f679082-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/6" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="6">(6) </num><chapeau>in subsection (j)—</chapeau><subparagraph class="fontsize10" id="y7f679083-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/6/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>in paragraph (1), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>for grants awarded prior to the date of enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2025</quotedText>” after “<quotedText>grant period under this section</quotedText>”; and</content></subparagraph>
<subparagraph class="fontsize10" id="y7f679084-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/6/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><chapeau>in paragraph (2)—</chapeau><clause class="fontsize10" id="y7f679085-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/6/B/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content>in the matter preceding subparagraph (A), by <amendingAction type="delete">striking</amendingAction> “<quotedText>2 years after submitting the preliminary report required under paragraph (1)</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>September 30, 2030</quotedText>”; and</content></clause>
<clause class="fontsize10" id="y7f679086-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/6/B/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><content>in subparagraph (A), by <amendingAction type="delete">striking</amendingAction> “<quotedText>(g)(3)</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>(g)(1)(C)</quotedText>”; and</content></clause>
</subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f679087-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/a/7" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="7">(7) </num><content><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f679088-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Time periods.</p></sidenote>in subsection (k), by <amendingAction type="delete">striking</amendingAction> “<quotedText>$5,000,000 for each of fiscal years 2019 through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>$12,000,000 for each of fiscal years 2026 through 2030</quotedText>”.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f679089-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Reauthorization of the CAREER Act; Recovery Housing Pilot Program</inline>.—</heading><page identifier="/us/stat/139/688">139 STAT. 688</page>
<paragraph class="fontsize10" id="y7f67908a-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1" role="instruction" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><heading class="fontsize10"><inline class="smallCaps">In general</inline>.—</heading><chapeau>Section 8071 of the SUPPORT for Patients and Communities Act (<ref href="/us/usc/t42/s5301">42 U.S.C. 5301 note</ref>; <ref href="/us/pl/115/271">Public Law 115–271</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><subparagraph class="fontsize10" id="y7f67908b-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><content>by <amendingAction type="delete">striking</amendingAction> the section heading and <amendingAction type="insert">inserting</amendingAction> “<quotedText>career act; recovery housing pilot program</quotedText>”;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f67908c-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><content>in subsection (a), by <amendingAction type="delete">striking</amendingAction> “<quotedText>through 2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>through 2030</quotedText>”;</content></subparagraph>
<subparagraph class="fontsize10" id="y7f67908d-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/C" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="C">(C) </num><chapeau>in subsection (b)—</chapeau><clause class="fontsize10" id="y7f67908e-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/C/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><content><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f67908f-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Deadline.</p></sidenote>in paragraph (1), by <amendingAction type="delete">striking</amendingAction> “<quotedText>not later than 60 days after the date of enactment of this Act</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>not later than 60 days after the date of enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2025</quotedText>”; and</content></clause>
<clause class="fontsize10" id="y7f679090-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/C/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><chapeau>in paragraph (2)(B)(i)—</chapeau><subclause class="fontsize10" id="y7f679091-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/C/ii/I" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">(I) </num><chapeau>in subclause (I)—</chapeau><item class="fontsize10" id="y7f679092-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/C/ii/I/aa" style="-uslm-lc:I658130"><num class="fontsize10" style="-uslm-lc:emspace2" value="aa">(aa) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>for calendar years 2013 through 2017</quotedText>”; and</content></item>
<item class="fontsize10" id="y7f679093-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/C/ii/I/bb" style="-uslm-lc:I658130"><num class="fontsize10" style="-uslm-lc:emspace2" value="bb">(bb) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>for calendar years 2018 through 2022</quotedText>” after “<quotedText>rates of unemployment</quotedText>”;</content></item>
</subclause>
<subclause class="fontsize10" id="y7f679094-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/C/ii/II" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">(II) </num><chapeau>in subclause (II)—</chapeau><item class="fontsize10" id="y7f679095-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/C/ii/II/aa" style="-uslm-lc:I658130"><num class="fontsize10" style="-uslm-lc:emspace2" value="aa">(aa) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>for calendar years 2013 through 2017</quotedText>”; and</content></item>
<item class="fontsize10" id="y7f679096-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/C/ii/II/bb" style="-uslm-lc:I658130"><num class="fontsize10" style="-uslm-lc:emspace2" value="bb">(bb) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>for calendar years 2018 through 2022</quotedText>” after “<quotedText>participation rates</quotedText>”; and</content></item>
</subclause>
<subclause class="fontsize10" id="y7f679097-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/C/ii/III" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="III">(III) </num><content>by <amendingAction type="delete">striking</amendingAction> subclause (III) and <amendingAction type="insert">inserting</amendingAction> the following:<quotedContent><subclause class="indentUp0 fontsize10" id="y7f67b7a8-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="III">“(III) </num><content>The highest age-adjusted average rates of drug overdose deaths for calendar years 2018 through 2022 based on data from the Centers for Disease Control and Prevention, including, if necessary, provisional data for calendar year 2022.”</content></subclause>
</quotedContent>; and</content></subclause>
</clause>
</subparagraph>
<subparagraph class="fontsize10" id="y7f67b7a9-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/1/D" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="D">(D) </num><content>in subsection (f), by <amendingAction type="delete">striking</amendingAction> “<quotedText>For the 2-year period following the date of enactment of this Act, the</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>The</quotedText>”.</content></subparagraph>
</paragraph>
<paragraph class="fontsize10" id="y7f67b7aa-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/b/2" role="instruction" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><heading class="fontsize10"><inline class="smallCaps">Conforming amendment</inline>.—</heading><content>Subtitle F of title VIII of the SUPPORT for Patients and Communities Act (<ref href="/us/pl/115/271">Public Law 115–271</ref>; <ref href="/us/stat/132/4095">132 Stat. 4095</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> the subtitle heading and <amendingAction type="insert">inserting</amendingAction> the following: “<quotedText><b>Subtitle F—CAREER Act; Recovery Housing Pilot Program</b></quotedText>” <b>.</b></content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f67b7ab-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/c" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">(c) </num><heading class="fontsize10"><inline class="smallCaps">Clerical Amendments</inline>.—</heading><chapeau>The table of contents in section 1(b) of the SUPPORT for Patients and Communities Act (<ref href="/us/pl/115/271">Public Law 115–271</ref>; <ref href="/us/stat/132/3894">132 Stat. 3894</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f67b7ac-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/c/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>by <amendingAction type="delete">striking</amendingAction> the item relating to section 7183 and <amendingAction type="insert">inserting</amendingAction> the following:<quotedContent><toc>
<referenceItem role="section" style="-uslm-lc:I658242">
<designator>“Sec. 7183. </designator>
<label>CAREER Act; treatment, recovery, and workforce support grants.”;<?GPOvSpace 04?></label>
</referenceItem></toc>
</quotedContent></content></paragraph>
<paragraph class="fontsize10" id="y7f67b7ad-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/c/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>by <amendingAction type="delete">striking</amendingAction> the item relating to subtitle F of title VIII and <amendingAction type="insert">inserting</amendingAction> the following:<quotedContent><toc>
<referenceItem role="subtitle" style="-uslm-lc:I658274">
<designator>“Subtitle F—</designator>
<label>CAREER Act; Recovery Housing Pilot Program”; and<?GPOvSpace 04?></label>
</referenceItem></toc>
</quotedContent></content></paragraph>
<paragraph class="fontsize10" id="y7f67b7ae-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s305/c/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content>by <amendingAction type="delete">striking</amendingAction> the item relating to section 8071 and <amendingAction type="insert">inserting</amendingAction> the following:<quotedContent><toc>
<referenceItem role="section" style="-uslm-lc:I658242">
<designator>“Sec. 8071. </designator>
<label>CAREER Act; Recovery Housing Pilot Program.”.</label>
</referenceItem></toc>
</quotedContent><page identifier="/us/stat/139/689">139 STAT. 689</page></content></paragraph>
</subsection>
</section>
<section id="d3755e3624" identifier="/us/pl/119/44/tIII/s306" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="306">SEC. 306. </num><heading>ADDRESSING ECONOMIC AND WORKFORCE IMPACTS OF THE OPIOID CRISIS.</heading><content style="-uslm-lc:I658120"> Section 8041(g)(1) of the SUPPORT for Patients and Communities Act (<ref href="/us/usc/t29/s3225a/g/1">29 U.S.C. 3225a(g)(1)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> “<quotedText>2023</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>2030</quotedText>”.</content></section>
<section id="d3755e3643" identifier="/us/pl/119/44/tIII/s307" style="-uslm-lc:I658143"><num class="fontsize12" value="307">SEC. 307. </num><heading>REVIEW OF INFORMATION RELATED TO FUNDING OPPORTUNITIES UNDER PROGRAMS ADMINISTERED BY SAMHSA.</heading><subsection class="firstIndent0 fontsize10" id="y7f6853ef-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s307/a" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f6853f0-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Deadline.</p><p class="leftAlign firstIndent0 fontsize8" id="x7f6853f1-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Public information.</p></sidenote><inline class="smallCaps">In General</inline>.—</heading><content>Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the “Secretary”) shall convene a public meeting for purposes of improving awareness of, and access to, information related to current and future funding opportunities under programs administered by the Substance Abuse and Mental Health Services Administration (in this section referred to as “SAMHSA funding opportunities”).</content></subsection>
<subsection class="firstIndent0 fontsize10" id="y7f6853f2-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s307/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><inline class="smallCaps">Topics</inline>.—</heading><chapeau>The public meeting under subsection (a) shall include—</chapeau><paragraph class="fontsize10" id="y7f6853f3-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s307/b/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>opportunities to improve the utility and functionality of internet websites maintained by the Secretary that provide information related to SAMHSA funding opportunities, such as Grants.gov;</content></paragraph>
<paragraph class="fontsize10" id="y7f6853f4-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s307/b/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>other models for displaying and disseminating information related to SAMHSA funding opportunities, such as interactive dashboards; and</content></paragraph>
<paragraph class="fontsize10" id="y7f6853f5-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s307/b/3" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="3">(3) </num><content><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f6853f6-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180">Strategies.</p></sidenote>strategies to improve the ability of entities to apply for SAMHSA funding opportunities, including entities that have not traditionally applied for SAMHSA funding opportunities.</content></paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f6853f7-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s307/c" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="c">(c) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f6853f8-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180"><ref href="/us/usc/t42/s290aa">42 USC 290aa note</ref>.</p></sidenote><inline class="smallCaps">Website Improvements</inline>.—</heading><content>The Secretary shall implement improvements to Grants.gov related to SAMHSA funding opportunities based on stakeholder feedback received at the public meeting under subsection (a), as appropriate, to the maximum extent feasible.</content></subsection>
<subsection class="firstIndent0 fontsize10" id="y7f6853f9-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s307/d" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="d">(d) </num><heading class="fontsize10"><inline class="smallCaps">Report</inline>.—</heading><chapeau>Not later than one year after the date on which the public meeting under subsection (a) is convened, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report summarizing the findings of such meeting, including how the Secretary has taken into account the feedback received through such meeting and implemented—</chapeau><paragraph class="fontsize10" id="y7f6853fa-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s307/d/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>improvements to internet websites maintained by the Secretary that provide information related to SAMHSA funding opportunities; and</content></paragraph>
<paragraph class="fontsize10" id="y7f6853fb-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIII/s307/d/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><content>strategies to improve awareness of SAMHSA funding opportunities.</content></paragraph>
</subsection>
</section>
<num value="IV">TITLE IV—</num><heading>MISCELLANEOUS MATTERS</heading>
<section id="d3755e3729" identifier="/us/pl/119/44/tIV/s401" role="instruction" style="-uslm-lc:I658143"><num class="fontsize12" value="401">SEC. 401. </num><heading>DELIVERY OF A CONTROLLED SUBSTANCE BY A PHARMACY TO A PRESCRIBING PRACTITIONER.</heading><content class="firstIndent0 fontsize10" id="x7f687b0c-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658120"> Section 309A(a) of the Controlled Substances Act (<ref href="/us/usc/t21/s829a/a">21 U.S.C. 829a(a)</ref>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="delete">striking</amendingAction> paragraph (2) and <amendingAction type="insert">inserting</amendingAction> the following:<page identifier="/us/stat/139/690">139 STAT. 690</page><quotedContent><paragraph class="fontsize10" id="y7f68a21d-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">“(2) </num><chapeau>the controlled substance is a drug in schedule III, IV, or V to be administered—</chapeau><subparagraph class="fontsize10" id="y7f68a21e-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">“(A) </num><content>by injection or implantation for the purpose of maintenance or detoxification treatment; or</content></subparagraph>
<subparagraph class="fontsize10" id="y7f68a21f-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">“(B) </num><content>subject to a risk evaluation and mitigation strategy pursuant to section 505–1 of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/t21/s355–1">21 U.S.C. 355–1</ref>) that includes elements to assure safe use of the drug described in subsection (f)(3)(E) of such section, including a requirement for post-administration monitoring by a health care provider;”</content></subparagraph>
</paragraph>
</quotedContent>.</content></section>
<section id="d3755e3772" identifier="/us/pl/119/44/tIV/s402" style="-uslm-lc:I658143"><num class="fontsize12" value="402">SEC. 402. </num><heading>REQUIRED TRAINING FOR PRESCRIBERS OF CONTROLLED SUBSTANCES.</heading><subsection class="firstIndent0 fontsize10" id="y7f696570-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a" role="instruction" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="a">(a) </num><heading class="fontsize10"><inline class="smallCaps">In General</inline>.—</heading><chapeau>Section 303 of the Controlled Substances Act (<ref href="/us/usc/t21/s823">21 U.S.C. 823</ref>) <amendingAction type="amend">is amended</amendingAction>—</chapeau><paragraph class="fontsize10" id="y7f696571-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/1" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="1">(1) </num><content>by <amendingAction type="redesignate">redesignating</amendingAction> the second subsection designated as subsection (l) as subsection (m); and</content></paragraph>
<paragraph class="fontsize10" id="y7f696572-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2" style="-uslm-lc:I658122"><num class="fontsize10" style="-uslm-lc:emspace2" value="2">(2) </num><chapeau>in subsection (m)(1), as so redesignated—</chapeau><subparagraph class="fontsize10" id="y7f696573-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/A" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="A">(A) </num><chapeau>in subparagraph (A)—</chapeau><clause class="fontsize10" id="y7f696574-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/A/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><chapeau>in clause (iv)—</chapeau><subclause class="fontsize10" id="y7f696575-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/A/i/I" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">(I) </num><chapeau>in subclause (I)—</chapeau><item class="fontsize10" id="y7f696576-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/A/i/I/aa" style="-uslm-lc:I658130"><num class="fontsize10" style="-uslm-lc:emspace2" value="aa">(aa) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>the American Academy of Family Physicians, the American Podiatric Medical Association, the Academy of General Dentistry, the American Optometric Association,</quotedText>” before “<quotedText>or any other organization</quotedText>”;</content></item>
<item class="fontsize10" id="y7f696577-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/A/i/I/bb" style="-uslm-lc:I658130"><num class="fontsize10" style="-uslm-lc:emspace2" value="bb">(bb) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>or the Commission</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>, the Commission</quotedText>”; and</content></item>
<item class="fontsize10" id="y7f696578-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/A/i/I/cc" style="-uslm-lc:I658130"><num class="fontsize10" style="-uslm-lc:emspace2" value="cc">(cc) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>, or the Council on Podiatric Medical Education</quotedText>” before the semicolon at the end; and</content></item>
</subclause>
<subclause class="fontsize10" id="y7f696579-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/A/i/II" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">(II) </num><content>in subclause (III), by <amendingAction type="insert">inserting</amendingAction> “<quotedText>or the American Academy of Family Physicians</quotedText>” after “<quotedText>Association</quotedText>”; and</content></subclause>
</clause>
<clause class="fontsize10" id="y7f69657a-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/A/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><chapeau>in clause (v), in the matter preceding subclause (I)—</chapeau><subclause class="fontsize10" id="y7f69657b-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/A/ii/I" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">(I) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>osteopathic medicine, dental surgery</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>osteopathic medicine, podiatric medicine, dental surgery</quotedText>”; and</content></subclause>
<subclause class="fontsize10" id="y7f69657c-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/A/ii/II" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">(II) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>or dental medicine curriculum</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>or dental or podiatric medicine curriculum</quotedText>”; and</content></subclause>
</clause>
</subparagraph>
<subparagraph class="fontsize10" id="y7f69657d-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/B" style="-uslm-lc:I658124"><num class="fontsize10" style="-uslm-lc:emspace2" value="B">(B) </num><chapeau>in subparagraph (B)—</chapeau><clause class="fontsize10" id="y7f69657e-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/B/i" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="i">(i) </num><chapeau>in clause (i)—</chapeau><subclause class="fontsize10" id="y7f69657f-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/B/i/I" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">(I) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>the American Pharmacists Association, the Accreditation Council on Pharmacy Education, the American Psychiatric Nurses Association, the American Academy of Nursing, the American Academy of Family Physicians,</quotedText>” before “<quotedText>or any other organization</quotedText>”; and</content></subclause>
<subclause class="fontsize10" id="y7f696580-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/B/i/II" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">(II) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>, the American Academy of Family Physicians,</quotedText>” before “<quotedText>or the Accreditation Council</quotedText>”; and</content></subclause>
</clause>
<clause class="fontsize10" id="y7f696581-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/B/ii" style="-uslm-lc:I658126"><num class="fontsize10" style="-uslm-lc:emspace2" value="ii">(ii) </num><chapeau>in clause (ii)—</chapeau><subclause class="fontsize10" id="y7f696582-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/B/ii/I" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="I">(I) </num><content>by <amendingAction type="delete">striking</amendingAction> “<quotedText>or accredited school</quotedText>” and <amendingAction type="insert">inserting</amendingAction> “<quotedText>, an accredited school</quotedText>”; and<page identifier="/us/stat/139/691">139 STAT. 691</page></content></subclause>
<subclause class="fontsize10" id="y7f696583-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/a/2/B/ii/II" style="-uslm-lc:I658128"><num class="fontsize10" style="-uslm-lc:emspace2" value="II">(II) </num><content>by <amendingAction type="insert">inserting</amendingAction> “<quotedText>, or an accredited school of pharmacy</quotedText>” before “<quotedText>in the United States</quotedText>”.</content></subclause>
</clause>
</subparagraph>
</paragraph>
</subsection>
<subsection class="firstIndent0 fontsize10" id="y7f696584-d532-11f0-b8a8-e1b4a9a7cc9b" identifier="/us/pl/119/44/tIV/s402/b" style="-uslm-lc:I658120"><num class="fontsize10" style="-uslm-lc:emspace2" value="b">(b) </num><heading class="fontsize10"><sidenote><p class="leftAlign firstIndent0 fontsize8" id="x7f696585-d532-11f0-b8a8-e1b4a9a7cc9b" style="-uslm-lc:I658180"><ref href="/us/usc/t21/s823">21 USC 823 note</ref>.</p></sidenote><inline class="smallCaps">Effective Date</inline>.—</heading><content>The amendment made by subsection (a) shall take effect as if enacted on December 29, 2022.</content></subsection>
</section>
ApprovedDecember 1, 2025.LEGISLATIVE HISTORY—H.R. 2483:HOUSE REPORTS: ┐No. 119–114, Pt. 1 (Comm. on Energy and Commerce).
CONGRESSIONAL RECORD, Vol. 171 (2025):